NEUROCOGNITIVE

Clinical trials for NEUROCOGNITIVE explained in plain language.

Never miss a new study

Get alerted when new NEUROCOGNITIVE trials appear

Sign up with your email to follow new studies for NEUROCOGNITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Hope for preemies: drug trial aims to shield tiny brains

Disease control Completed

This large study tested whether a weekly drug called darbepoetin could improve brain development and thinking skills in extremely premature infants. It involved 650 babies born between 23 and 28 weeks. The goal was to see if the drug, which helps make red blood cells and may prot…

Matched conditions: NEUROCOGNITIVE

Phase: PHASE3 • Sponsor: NICHD Neonatal Research Network • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

NEUROCOGNITIVE

Get alerted when new NEUROCOGNITIVE trials appear

Hope for preemies: drug trial aims to shield tiny brains